0001104659-21-146360.txt : 20211203 0001104659-21-146360.hdr.sgml : 20211203 20211203161618 ACCESSION NUMBER: 0001104659-21-146360 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211203 DATE AS OF CHANGE: 20211203 EFFECTIVENESS DATE: 20211203 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Petros Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001815903 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851410058 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-423627 FILM NUMBER: 211470231 BUSINESS ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 973-242-0005 MAIL ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 D 1 primary_doc.xml X0708 D LIVE 0001815903 Petros Pharmaceuticals, Inc. 1185 AVENUE OF THE AMERICAS, SUITE 249 NEW YORK NY NEW YORK 10036 (973) 242-0005 DELAWARE None None Corporation true 2020 Mitchell Arnold 1185 Avenue of the Americas, Suite 249 New York NY NEW YORK 10036 Executive Officer Vice President of Finance and Principal Accounting Officer Fady Boctor 1185 Avenue of the Americas, Suite 249 New York NY NEW YORK 10036 Executive Officer President and Chief Commercial Officer John D. Shulman 1185 Avenue of the Americas, Suite 249 New York NY NEW YORK 10036 Director Joshua N. Silverman 1185 Avenue of the Americas, Suite 249 New York NY NEW YORK 10036 Director Bruce T. Bernstein 1185 Avenue of the Americas, Suite 249 New York NY NEW YORK 10036 Director Gregory Bradley 1185 Avenue of the Americas, Suite 249 New York NY NEW YORK 10036 Director Wayne R. Walker 1185 Avenue of the Americas, Suite 249 New York NY NEW YORK 10036 Director Andrew Gesek 1185 Avenue of the Americas, Suite 249 New York NY NEW YORK 10036 Executive Officer President, Timm Medical Pharmaceuticals Decline to Disclose 06b false 2021-11-29 false true true true false 0 12815000 3540000 9275000 1180000 shares of common stock at $3/sh, warrants to purchase up to 2500000 shares of common stock at $3.50/sh, & warrants to purchase up to 150000 shares of common stock at $3.50/sh issued to financial advisor in connection w/ offerings closed on 12/2/21 false 12 0 0 0 false Petros Pharmaceuticals, Inc. /s/ Mitchell Arnold Mitchell Arnold Vice President of Finance and Principal Accounting Officer 2021-12-03